Core Viewpoint - JYSW003 project by Tianjin Pharmaceutical Industry Co., Ltd. shows promising efficacy and safety for psoriasis treatment, with ongoing exploratory research [1] Group 1 - The JYSW003 project is an innovative drug initiative commissioned by Tianjin Pharmaceutical's innovation research institute [1] - Preliminary research results indicate significant drug efficacy and superior safety characteristics [1] - The company plans to establish an innovation research institute in 2024 to focus on drug design, discovery, and incubation [1] Group 2 - Current projects in the innovative drug pipeline are in the early exploratory research phase [1] - The company aims to enhance its product pipeline, accelerate diversified development, and concentrate resources on high-value products [1] - The strategy includes continuous project initiation to build product advantages and expand market space for optimized product structure [1]